Petxone 250mg Injection
Marketer
Vista Health Care
Salt Composition
Ceftriaxone (250mg)
Overview Petxone 250mg Injection
Cephalosporin antibiotic, Petxone 250mg Injection, combats bacterial infections throughout the body. Its applications encompass infections affecting the brain (such as meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, bloodstream, and heart. Prophylactically, it may prevent surgical site infections. Administered intravenously or via intramuscular injection by a healthcare provider, dosage is determined by your physician. Regular, evenly spaced doses, as directed, are crucial; completing the prescribed course is vital, even with symptom improvement, to prevent relapse. Common side effects may include diarrhea, skin rash, altered liver function test results, and variations in blood cell counts (e.g., elevated eosinophils, reduced white blood cells, low platelets). Transient injection site redness or pain is also possible. While usually mild, report persistent or bothersome side effects. Prior to use, disclose any antibiotic allergies, kidney or liver issues, and all other medications you are currently using to your doctor, as interactions are possible.
Primary Ingredients of Petxone 250mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Petxone 250mg Injection
Combating Bacterial Infections
Major Benefits of Petxone 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not recommended.
Common Side effects of Petxone 250mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Petxone 250mg Injection:
Administering this medication requires a healthcare professional; please do not self-medicate.
How Petxone 250mg Injection works:
Petxone 250mg Injection, an antibacterial agent, eradicates bacteria by inhibiting the synthesis of their essential protective cell wall, thus compromising their viability.
SAFETY ADVICE
AlcoholSAFE
Petxone 250mg Injection may be used concomitantly with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Petxone, 250mg, presents minimal to no documented fetal risk during gestation, according to the majority of research.
Breast feedingCAUTION
Administering Petxone 250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Petxone 250mg Injection might reduce vigilance, impair vision, and induce drowsiness or dizziness. Refrain from driving if these effects manifest.
KidneySAFE IF PRESCRIBED
Petxone 250mg Injection can be administered to patients with kidney disease without altering the dosage. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advised.
LiverCAUTION
The administration of Petxone 250mg Injection requires careful consideration in individuals with significant hepatic impairment, potentially necessitating dose modification. Consult a physician for guidance. Dosage alteration for Petxone 250mg Injection is not advised for those with less severe liver dysfunction.
What if you forget to take Petxone 250mg Injection :
Omit a Petxone 250mg Injection dose? Seek medical advice immediately.
Facts to Know About Petxone 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Advanced Cephalosporins (Third and Fourth Generation) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently